INTRAGO-Intraoperative Radiotherapy for Glioblastoma - a Phase I/II Study
NCT02104882
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
12
Enrollment
OTHER
Sponsor class
Conditions
Glioblastoma Multiforme
Interventions
RADIATION:
Intraoperative Radiotherapy (Applicator Surface Dose: 20-40 Gy)
Sponsor
Universitätsmedizin Mannheim